Switzerland· 44691086
Sirdalud 4 mg, Tabletten
A tizanidine product containing tizanidinum, registered in Switzerland by Sandoz Pharmaceuticals AG and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 14 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Tizanidine is registered in 14 of 19 countries.
Countries holding a registration under ATC M03BX02 (tizanidine), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 7 of them publish a price we can compare per daily dose
Tizanidine · ATC M03BX02
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of tizanidine costs, country by country.
Normalised to the WHO defined daily dose (12 mg), so markets compare like for like.
- Switzerland: $2.38 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Tizanidine · price per daily dose (12 mg)
USD · FX 28 Sept 2026
- CH Switzerland$2.38
The record
At a glance
Swissmedic (Switzerland)- Active substance
- tizanidinum
- Manufacturer
- Sandoz Pharmaceuticals AG
- Country
- Switzerland (CH)
- ATC code
- M03BX02
- ATC class
- Tizanidine
- Defined daily dose
- 12 mg, O
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin768044691086114 StkCHF 14.65
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
384 interactions on record for tizanidine.
Graded by severity as the source publishes them — 78 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tizanidine · interactions on record
384 records
- 78 severe
- 177 moderate
- 2 minor
- 87 info
Most severe, free to view
- CimetidineA02BA01severe
- FamotidineA02BA03severe
- PapaverineA03AD01severe
- CisaprideA03FA02severe
40 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Tizanidine in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatestizanidineREMEDYREPACK INC.
- United KingdomTizagelan 4mg tabletsG.L. Pharma UK Ltd
- PolandChordynaBausch Health Ireland Ltd.
- FinlandSirdaludSandoz A/S
- NetherlandsChordyna 4 mg, tablettenBausch Health Ireland Limited
- IrelandZanaflex 4 mg TabletsPCO Manufacturing Ltd.
- NorwaySirdaludBexal
- CanadaAPO-TIZANIDINEAPOTEX INC
Authorised across Europe · EMA
The same active substance is authorised in 23 EEA countries. Names it is sold under:
- Austria · Sirdalud, Sirdalud Mr
- Belgium · Sirdalud
- Bulgaria · Tizanidine Teva, Тизанидин Tева
- Czechia · Sirdalud
- Germany · Sirdalud, Tizanidin Ascend
- Denmark · Sirdalud Retard, Tizanidin Teva
- Estonia · Sirdalud
- Spain · Sirdalud
- Finland · Sirdalud, Sirdalud Retard
- United Kingdom (Northern Ireland) · Tizagelan, Tizanidine
- Greece · Sirdalud
- Croatia · Tizanidin Altamedics
- Hungary · Sirdalud, Sirdalud Mr
- Ireland · Tizanidine Teva
- Italy · Navizan, Sirdalud
- Lithuania · Sirdalud
- Luxembourg · Sirdalud
- Latvia · Sirdalud
- Netherlands · Chordyna, Sirdalud
- Poland · Chordyna, Sirdalud Mr
- Portugal · Sirdalud, Tizanidina Teva
- Slovenia · Sirdalud
- Slovakia · Sirdalud
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5af7dd40-5eba-448b-aa76-d4f454679737 GET /v1/drugs/5af7dd40-5eba-448b-aa76-d4f454679737?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "tizanidinum 4 mg",
"valid_from": "1992-03-15",
"limitations": null,
"galenic_form": "Tabl 4 mg",
"therapeutic_area": null,
"sl_inclusion_date": "1992-03-15",
"self_retention_pct": 10
}See everything about tizanidine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.